Benjamin Markman (Ben Markman)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Randomized Controlled Trial

Metastatic Colorectal Cancer

Microbial Community

Epidermal Growth Factor Receptor

Top Venues

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine 30 (3) (2024)
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine (2024)
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine 30 (3) (2024)
Kortnye Smith, Sophie O'Haire, Benjamin Markman, Hui Kong Gan, Kenneth J O'Byrne, Michael Millward, Ben Tran, Benjamin J Solomon, Clare L Scott, Damien Kee, Grant A McArthur, Andrew P Fellowes, Dong Anh K Khoung-Quang, Paul G Ekert, Paul A James, Huiling Xu, Melissa Martyn, Elly Lynch, Rona Weerasuriya, Clara L Gaff, Stephen B Fox, Jayesh Desai
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery. JCO precision oncology 8 (2024)
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine 30 (3) (2024)
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine 30 (3) (2024)
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine 30 (3) (2024)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
Phase Ib/II Trial of BRAF and EGFR inhibition in BRAFV600E metastatic colorectal cancer and other cancers: EVICT (Erlotinib and Vemurafenib In Combination Trial). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)